Top Markets
Coin of the day
Golden Biotechnology Corporation Golden Biotechnology Corporation

Golden Biotechnology Corporation

4132
주식 순위 #29679
Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City,... Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City, Taiwan, is engaged in both pharmaceutical drug discovery and the production of health-enhancing dietary supplements. The company operates internationally, serving markets in Taiwan, the United States, Japan, China, Korea, and Singapore. Its varied product line includes several health supplements: Liverty, formulated to support liver function and help alleviate fatigue. Rasle, which serves as an adjunctive therapy for autoimmune conditions. ZSAINO, a nutritional product designed to aid recovery from illness and boost general well-being. UMOOZE, a specialized herbal blend targeting optimal health for men. Furthermore, Golden Biotechnology is developing Antroquinonol, an anticancer molecule. This compound is currently utilized in the treatment of severe conditions such as pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, in addition to addressing hypercholesterolemia and hyperlipidemia.
주가
$0.11034263
마지막 동기화: 2026-04-09
시가총액
$20.11M
변동 (1일)
-31.83%
변동 (1년)
-73.09%
국가
TW
거래 Golden Biotechnology Corporation (4132)

카테고리

Golden Biotechnology Corporation (4132)의 주식 분할 이력
Golden Biotechnology Corporation 주식 (심볼: 4132)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 19, 2026에 발생했습니다.
Aug 19, 2026 이전에 매수한 4132 주식 1주는 현재 0주의 4132 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할